期刊文献+

苯乙酸钠诱导人前列腺癌细胞凋亡及其机理的研究 被引量:2

Study on apoptosis and its mechanism induced by NaPA in PC-3 cell
下载PDF
导出
摘要 目的 探讨苯乙酸钠 (Na PA)诱导人前列腺癌细胞株 (PC- 3)凋亡及其分子机理。方法 应用流式细胞术 (FCM)观察不同剂量 Na PA对 PC- 3细胞周期改变的影响 ,通过 RT- PCR检测 bcl- 2和增殖细胞核抗原 (PCNA)在 m RNA水平的表达。结果  PC- 3细胞体外经不同剂量 (0m M/ L,1 .5m M/ L,3.0 m M/ L,6.0 m M/ L) Na PA处理后 ,细胞周期的 G0 / G1 期升高 ,S期、G2 / M期相对下降 ,G0 / G1 峰前有明显的亚二倍体峰 ,即凋亡峰 ,且随着 Na PA浓度的增加 ,凋亡细胞数逐渐增多 (P<0 .0 0 1 ) ;bcl- 2和 PCNA在 m RNA水平随 Na PA剂量的增加 ,表达量下降。结论 Na PA可能通过下调 bcl- 2和 PCNA在 m RNA水平的表达诱导 PC- 3细胞凋亡。 Objective To study apoptosis and its molecular mechanism induced by sodium phenylacetate (NaPA) in human prostate carcinoma cell strain (PC-3).Methods The effects of NaPA with different dosages (0 mM/L;1.5 mM/L; 3.0 mM/L; 6.0 mM/L) on the biological changes of apoptosis and cell cycle in PC-3 were observed by flow cytometry technique (FCM). The mRNA expression level of bcl-2 and PCNA was detected by RT-PCR.Results PC-3 cell growth was inhibited and apoptosis was induced by NaPA in a dose-dependent manner. The G 0/G 1 phase cells significantly increased and S or G 2/M phase cells relatively decreased afer the treatment.The bcl-2 and PCNA mRNA expression levels decreased with dosage-dependent of NaPA increasing.Conclusions The PC-3 cell apoptosis induced by NaPA may be regulated by decreasing the expression of bcl-2 and PCNA on the mRNA level.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2003年第11期764-766,共3页 Chinese Journal of Gerontology
基金 深圳市卫生局科研基金资助 (2 0 0 1 - 0 4 - 0 1 7)
关键词 苯乙酸钠 前列腺癌 细胞凋亡 作用机理 流式细胞术 RT—PCR 增殖细胞核抗原 Sodium Phenylacetate (NaPA) Prostate carcinoma cell stain (PC-3) Apoptosis bcl-2 gene PCNA gene
  • 相关文献

参考文献13

  • 1Samid D,Hudgins WR,Shack S,et al. Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers[J].Adv Exp Med Biol,1997~400A:501-505.
  • 2Samid D,Shack S,Sherman LT. Phenylacetate : A novel nontoxic inducer of tumor cell differentiation [J]. Cancer Res, 1992 ; 52 : 1988-1992.
  • 3Nicoletti I, Migliorati G, Pagliacci MC,et al. A rapid and simple method for measuring thymocytle apoptosis by propidium iodide staining and flow cytometry [J] J Immunol Methods, 1991; 139:271-279.
  • 4Markus M, Cbarles E, Oliver S, et al. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3[J]. Cancer Res, 1995 ; 55 : 2122-2128.
  • 5Sklar GN, Eddy HA,Jacobs SC ,et al. Combined antitumor effect of suram in plus irradiation in human an prostate cancer: The role apoptosis[J]. J Llrol,1993;150:1526-1533.
  • 6Berges RR, Ruruga Y, Remington L,et al. Cell proliferation are not required for programmed death of prostatic[J]. Pro Natl Acad Sei USA, 1993 ; 90: 8910-8919.
  • 7Gree DR, Reed JC. Mitochondria and apoptosis [J ]. Science, 1998;281 : 1309-1316.
  • 8A dams JM,Cory S-The bcl-2 protein family:Arbiters of cell sarvivas[ J]. Science, 1998 ; 291 : 1322-1329.
  • 9Carey FA,Fabbroni G,Lamb D. Expression of proliferating cell nuclear antigen in lung cancer:A systematic study and correlation with DNA ploidy [J]. Histopathology, 1992 ; 20: 499-503.
  • 10Garcia PL,Coltrera MD,Gown AM. Analysis of proliferative grade using anti-PCNA/Cyclin monoclonalantibodies in fixed,embedded tissues. Comparison with flow cytometric analysis [J].Am J Pathol, 1989 ; 134 : 733-740.

同被引文献27

  • 1[1]Coffey RN, Watson RW, Fitzpatrick JM, et al. Androgen-mediated resistance to apoptosis [J]. Prostate, 2002, 53:300 ~ 309.
  • 2[2]Mceleny KR, Watson RW, Coffey RN, et al. Inhibitors of apoptosis proteins in prostate cancer cell lines [J]. Prostate, 2002, 51(2): 133~ 140.
  • 3[4]Samid D, Hudgins W, Shack S, et al. Phenylacetate and pheylbutyrate as novel, nontoxic differentiation inducers [J].Adv Exp Med Biol, 1997,400A:501~ 505.
  • 4[5]Samid D, Shack S, Sherman LT. Phenylacetate:a novel nontoxic inducer of tumor cell differentiation[J].Cancer Research, 1992,52:1988 ~ 1992.
  • 5[6]Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and smiple method for measuring thym ocytle apoptosis by propidium iodide staining and flow cytometry[J]. J Immunol Methods, 1991,139:271~279.
  • 6[7]Ross R.Platelet derived growth factor[J].Lancet, 1999,11:1179~ 1182.
  • 7[8]Antoniades HN, Hunkapiller MW. Human platelet derived growth factor (PDGF):amino terminal amino acid sequence [J].Science, 1999,230:963~ 965.
  • 8[9]Jin HM, Robinson DF, Liang Y,et al. SIS/PDGF-B promoter isolation and characterization of regulatory elements necessary for basal expression of the SIS/PDGF-B gene in U2-osteosarcoma cells[J].J Biol Chem,1994, 269:28648 ~28654.
  • 9[10]Wang ZY, Madden SL, Deuel TF, et al. The Wilms tumor gene product, WT1, represses transcription of the plateletderived growth factor A chain gene[J].J Biol Chem, 1999,267:21999 ~ 22002.
  • 10[11]Uehara H, kim SJ, Karashima T, et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases [J].J Natl Cancer Inst, 2003,95(6):458~470.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部